Answers are grounded in this paper and cite their sources.
The clinical benefit of lowering Lp(a) is likely to be proportional to the absolute reduction in Lp(a) concentration. Large absolute reductions in Lp(a) of approximately 100 mg/dL may be required to produce a clinically meaningful reduction in the risk of CHD similar in magnitude to what can be achieved by lowering LDL-C level by 38.67 mg/dL (ie, 1 mmol/L).
No takes yet. Share an insight, caveat, or question.
Burgess et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: